Leader in Government Reimbursement
We are a data analytics company that helps providers maximize governmental program reimbursements. Over the years, we've found hospitals close to $1 billion in additional revenue and savings.
We focus on the federally-funded Medicare DSH / Uncompensated Care and 340B Drug Pricing Programs. We're continually developing new solutions to help providers keep the dollars they deserve.
COMPASS is the technology the helps us find providers additional reimbursement dollars. Our advanced algorithms and intelligent queries uncover "hidden eligibility" others cannot.
We brought NAVEOS as a third opinion vendor and were quite skeptical that they could produce anything near what their conservative projections were; four years and $9 million in supplemental Federal DSH reimbursement later, they are our primary and only vendor and handle the full spectrum of DSH/340B management for us.
Corporate Director of Reimbursement, University Teaching Facility, Virginia
In 2005, we were notified by the Fiscal Intermediary that they had made an audit adjustment to our DSH Log from our prior vendor that would have resulted in the loss of our entire DSH payment. Within 60 days, NAVEOS intervened, identified and documented over 700 additional days, of which 100% were accepted by the FI including patient types they had never previously encountered. Since that time, NAVEOS has made our facility over $7 million in Federal DSH funds with zero audit adjustment.
Senior Vice President of Finance, 400+ urban facility in Virginia
I tell our hospital members that the best analogy for the services you provide is to compare the role of a primary care physician to a sub-specialist; your sub-specialty expertise enables you to take a primary diagnosis and refine it to point where you can focus on the specific issues affecting our members.
Chief Operating Officer, Hospital Association
We engaged NAVEOS to handle multiple over-stated years done previously by the State that could have resulted in substantial reserve increases for Federal DSH. We later expanded the project scope to cover State DSH for a program we were told we no longer qualified for, potentially costing us $5.7 million per year. NAVEOS prepared a comprehensive appeal package and four iterative versions that convinced the State that its internal calculations were flawed, resulting in our continued participation in the fund.
Vice President of Finance for 5-Hospital System with 800-bed flagship hospital